Lung

AST/AJT Journal Club hosted by the PCOP

AST/AJT Journal Club hosted by the PCOP

Tuesday, September 17th, 2019, from 2:00 PM ET to 3:00 PM ET • Hosted by the Pediatric Community of Practice (PCOP)

"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."
(Am J Transplant. 2019 Jun 19. doi: 10.1111/ajt.15505.)

In this article:
[After following] 61 pediatric lung transplant recipients for 2+ years or until they met a composite primary endpoint including bronchiolitis obliterans syndrome/obliterative bronchiolitis, retransplant, or death..., findings raise the possibility that the immunologic impact of CARV following pediatric lung transplant is different than that observed in adults.

Speaker:
Stuart Sweet, MD, PhD • Washington University in St. Louis, St. Louis, MO

Moderator:
Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

AST/AJT Journal Clubs are free to both members and non-members. Pre-register today to support this Pediatric COP session, and please feel free to share the registration link with your colleagues!

"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."

"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."

Originally aired on Tuesday, September 17th, 2019, from 2:00 PM ET to 3:00 PM ET • Hosted by the Pediatric Community of Practice (PCOP)

"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."
(Am J Transplant. 2019 Jun 19. doi: 10.1111/ajt.15505.)

Watch Video

Chronic lung allograft dysfunction: Where are we now? (Tx10 Series)

"Chronic lung allograft dysfunction: Where are we now?" was recorded at ATC 2018 as part of our Transplant in 10 (Tx10) educational series. Visit our Tx10 page to view the corresponding video for this session.

Speaker: Allan Glanville, MBBS, MD, FRACP, St. Vincent's Hospital

Date: 
Monday, August 6, 2018
Presenter: 
Allan Glanville, MBBS, MD, FRACP, St. Vincent's Hospital
Education Category: 

"Geographic disparities in lung transplant rates"

Case-Based Multidisciplinary Approach to Cardiac and Pulmonary Vascular Disease Risk Assessment in Liver Transplantation

View Archive

Speakers:
Lisa VanWagner, MD, MSc, FAST, FAHA • Northwestern Medicine
Marina Serper, MD, MS • University of Pennsylvania
Christopher Darling, DO • University of Wisconsin

Moderator:
Shelley Hall, MD, FAST • Baylor University Medical Center - Dallas

After participating in this webinar, the learner will be able to:

"Zbtb7a Induction in Alveolar Macrophages is Implicated in Anti-HLA–Mediated Lung Allograft Rejection"

"Zbtb7a Induction in Alveolar Macrophages is Implicated in Anti-HLA–Mediated Lung Allograft Rejection"

Originally aired on November 20, 2017 • 12:00 PM ET • Hosted by the Community of Basic Scientists and the Thoracic and Critical Care Community of Practice

Zbtb7a Induction in Alveolar Macrophages is Implicated in Anti-HLA–Mediated Lung Allograft Rejection

Watch Video

Novel Immunosuppressants: Applicability to Thoracic Organ Transplantation?

View Archive

Speaker: Jon Kobashigawa, MD • Cedars Sinai Heart Institute
Moderator: Sean Pinney, MD • Mount Sinai School of Medicine

After participating in this webinar, the learner will be able to: 

  1. Relate the advances in immunosuppression therapy.
  2. Describe the mechanisms of immunosuppression.
  3. Identify the newer immunosuppression agents and future therapies.

Pages

Subscribe to RSS - Lung